Citadel Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-501,911
Closed -$269K 16040
2024
Q4
$269K Buy
501,911
+261,506
+109% +$182K ﹤0.01% 9880
2024
Q3
$423K Buy
240,405
+236,840
+6,643% +$331K ﹤0.01% 8620
2024
Q2
$4.17K Sell
3,565
-1,240,275
-100% -$3.1M ﹤0.01% 13510
2024
Q1
$11.2M Buy
1,243,840
+647,444
+109% +$6.29M ﹤0.01% 2799
2023
Q4
$6.48M Buy
596,396
+118,387
+25% +$887K ﹤0.01% 3440
2023
Q3
$3.85M Buy
478,009
+175,697
+58% +$1.46M ﹤0.01% 4071
2023
Q2
$3.28M Buy
302,312
+118,904
+65% +$1.02M ﹤0.01% 4311
2023
Q1
$1.27M Sell
183,408
-169,045
-48% -$1.06M ﹤0.01% 6285
2022
Q4
$1.4M Buy
352,453
+120,625
+52% +$593K ﹤0.01% 6170
2022
Q3
$1.54M Buy
231,828
+12,338
+6% +$76K ﹤0.01% 6103
2022
Q2
$1.06M Buy
219,490
+191,640
+688% +$1.17M ﹤0.01% 6888
2022
Q1
$261K Sell
27,850
-196,490
-88% -$1.95M ﹤0.01% 10911
2021
Q4
$2.67M Buy
224,340
+172,888
+336% +$2M ﹤0.01% 5571
2021
Q3
$585K Sell
51,452
-163,563
-76% -$2.25M ﹤0.01% 9486
2021
Q2
$3.86M Buy
215,015
+185,724
+634% +$2.99M ﹤0.01% 5020
2021
Q1
$453K Buy
+29,291
New +$424K ﹤0.01% 9889
2020
Q4
Sell
-52,028
Closed -$725K 11672
2020
Q3
$668K Buy
52,028
+41,244
+382% +$356K ﹤0.01% 6777
2020
Q2
$109K Sell
10,784
-12,955
-55% -$119K ﹤0.01% 8946
2020
Q1
$192K Buy
23,739
+6,498
+38% +$56.3K ﹤0.01% 8050
2019
Q4
$149K Sell
17,241
-5,601
-25% -$31.4K ﹤0.01% 8369
2019
Q3
$141K Sell
22,842
-58,469
-72% -$472K ﹤0.01% 8330
2019
Q2
$1.35M Sell
81,311
-12,597
-13% -$219K ﹤0.01% 5194
2019
Q1
$1.57M Buy
93,908
+30,561
+48% +$440K ﹤0.01% 4855
2018
Q4
$727K Buy
63,347
+24,411
+63% +$494K ﹤0.01% 5803
2018
Q3
$1.56M Buy
38,936
+30,054
+338% +$855K ﹤0.01% 4811
2018
Q2
$251K Buy
8,882
+4,700
+112% +$104K ﹤0.01% 7520
2018
Q1
$64K Sell
4,182
-251,346
-98% -$5.98M ﹤0.01% 7854
2017
Q4
$8.34M Buy
255,528
+242,682
+1,889% +$6.54M 0.01% 1916
2017
Q3
$301K Buy
12,846
+9,843
+328% +$110K ﹤0.01% 6070
2017
Q2
$16K Sell
3,003
-5,953
-66% -$32.2K ﹤0.01% 7336
2017
Q1
$64K Buy
+8,956
New +$48.1K ﹤0.01% 6986